Search Results - "Otto, Tracey"
-
1
Hidradenitis Suppurativa: New Targets and Emerging Treatments
Published in American journal of clinical dermatology (01-09-2024)“…Hidradenitis suppurativa (HS) is a chronic inflammatory skin condition that can be challenging to treat. Biologics and targeted small molecules have become an…”
Get full text
Journal Article -
2
A Pearl for Pretibial and Forearm Repair Following Mohs Micrographic Surgery
Published in Journal of drugs in dermatology (01-05-2024)“…Wound repair of the pretibial and forearm regions presents a challenge during dermatologic surgery as these areas are under significant tension and exhibit…”
Get more information
Journal Article -
3
A retrospective study of idiopathic granulomatous mastitis diagnosis and clinical presentation
Published in Journal of the American Academy of Dermatology (01-02-2022)Get full text
Journal Article -
4
A Retrospective Study of Idiopathic Granulomatous Mastitis Treatment and Outcomes
Published in Journal of drugs in dermatology (01-04-2022)“…Granulomatous mastitis (GM) is a rare, poorly characterized inflammatory disease with a broad differential diagnosis that includes both benign and malignant…”
Get more information
Journal Article -
5
Limitations of morphology-based management for immune checkpoint inhibitor-related cutaneous adverse events
Published in Journal of the American Academy of Dermatology (01-06-2021)Get full text
Journal Article -
6
Methotrexate in the treatment of immune checkpoint blocker-induced bullous pemphigoid
Published in European journal of cancer (1990) (01-12-2021)Get full text
Journal Article -
7
-
8
Low grade cutaneous immune related adverse events leading to immunotherapy discontinuation
Published in Clinical and experimental dermatology (25-08-2023)“…Cutaneous immune-related adverse events (cirAEs) are a common toxicity arising from the use of immune checkpoint inhibitors (ICIs) to treat cancer. We provide…”
Get full text
Journal Article -
9
-
10
Response to: “Immune checkpoint inhibitor-related Stevens-Johnson syndrome/toxic epidermal necrolysis-like reactions”
Published in Journal of the American Academy of Dermatology (01-08-2021)Get full text
Journal Article -
11
-
12
-
13
Immune checkpoint inhibitors in patients with pre-existing psoriasis: safety and efficacy
Published in Journal for immunotherapy of cancer (01-10-2021)“…BackgroundImmune checkpoint inhibitors (ICIs) are approved to treat multiple cancers. Retrospective analyses demonstrate acceptable safety of ICIs in most…”
Get full text
Journal Article -
14
Detection of novel therapies using a multi‐national, multi‐institutional registry of cutaneous immune‐related adverse events and management
Published in International journal of dermatology (01-08-2023)“…Background Cutaneous immune‐related adverse events (cirAEs) remain a prevalent and common sequelae of immune checkpoint inhibitor (ICI) therapy, often…”
Get full text
Journal Article -
15
-
16
Defining the Opioid Requirement in Anterior Cruciate Ligament Reconstruction
Published in Journal of the American Academy of Orthopaedic Surgeons. Global research & reviews (13-01-2022)“…The amount and duration of opioids necessary after anterior cruciate ligament reconstruction (ACLR) are inadequately defined. This study sought to…”
Get full text
Journal Article -
17
-
18
-
19
35328 Morbidities associated with solitary keratoacanthomas
Published in Journal of the American Academy of Dermatology (01-09-2022)Get full text
Journal Article -
20
Oral Psoriasis Therapies
Published in Dermatologic clinics (01-07-2024)“…Oral psoriasis therapies include both older traditional immunosuppressants, such as methotrexate, cyclosporine, and acitretin, as well as newer, more targeted…”
Get full text
Journal Article